A decrease of 570,000 or 1% year-over-year. “This was driven by attrition in our Medicaid business associated with the resumption of eligibility redeterminations in the second quarter of 2023 and declines in our Employer Group risk-based business. These membership losses were partially offset by growth in BlueCard, Affordable Care Act health plans, and Medicare Advantage.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ELV:
- Is ELV a Buy, Before Earnings?
- Early notable gainers among liquid option names on January 17th
- PEAK ROCK CAPITAL AFFILIATE SELLS PARAGON HEALTHCARE, INC. TO ELEVANCE HEALTH
- Peak Rock Capital affiliate to sell Paragon Healthcare to Elevance Health
- Elevance Health to buy Paragon Infusion for ‘well north’ of $1B, Axios says
